
a portfolio company of Gilde Healthcare
has been acquired by

February 2025
Managing Director, Healthcare IT
Matt Batterbury is a managing director for William Blair based in the firm’s London office. He joined William Blair's investment banking team in 2014.
City Harvest
a portfolio company of Gilde Healthcare
has been acquired by
February 2025
a portfolio company of Rivean Capital
has received a significant
strategic investment from
January 2025
William Blair acted as the exclusive financial advisor to Corilus N.V. (Corilus) and Rivean Capital (Rivean) in connection with a pending significant strategic investment from PSG Equity (PSG).
Read morea portfolio company of H.I.G. Capital
has been acquired by
January 2025
a portfolio company of Freshstream
has been acquired by
August 2024
a portfolio company of Longship
has been acquired by
August 2024
William Blair acted as the exclusive financial advisor to Sensio, a portfolio company of Longship, in connection with its pending sale to Nordic Capital.
Read morea subsidiary of Sartorius AG
has merged with
July 2024
have acquired
a portfolio company of August Equity
February 2024
a portfolio company of ECI Partners
has been acquired by
a portfolio company of EQT
April 2023
has been acquired by
August 2022
a portfolio company of Hg & Vista Equity Partners
has been acquired by
a portfolio company of Five Arrows Principal Investments & TA Associates
September 2021
William Blair acted as financial advisor to Allocate, a portfolio company of Hg and Vista Equity Partners (Vista), in connection with its pending sale to RLDatix, a portfolio company of Five Arrows Principal Investments and TA Associates.
Read morea portfolio company of TPG and LGP
has sold its International Medicines Management Business to
a portfolio company of CVC
July 2021
William Blair acted as the exclusive financial advisor to WellSky Corporation, a portfolio company of TPG Capital and Leonard Green & Partners, in connection with the sale of its International Medicines Management Business, WellSky International, to System C, a portfolio company of CVC Capital.
Read morea portfolio company of H2 Equity Partners
has been acquired by
April 2021
William Blair acted as the exclusive financial advisor to Primacy Healthcare 21 Limited, a portfolio company of H2 Equity Partners, in connection with its sale to AddLife AB.
Read moreOur investment bankers are 100 percent committed to your organization’s sustained success. By drawing on our deep industry and product experience as well as our dedicated global resources, we provide advisory and financing services that allow you to capitalize on today’s opportunities and anticipate tomorrow’s challenges.
More about investment banking at William BlairAs technology becomes an increasingly critical part of the effort to reduce healthcare costs, increase efficiency, and improve patient outcomes, we are committed to helping innovative healthcare IT companies accelerate their growth by accessing capital and forming strategic partnerships.
Learn more about our healthcare IT expertiseWilliam Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*
Year William Blair was founded
Employees worldwide
Client assets
Independent and employee-owned
Offices worldwide
Companies under coverage
As of December 31, 2024
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.
This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.
Copyright © 2025 William Blair & Company, L.L.C. | Privacy Terms
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures